GSAC GelStat Corp. featured news, full reports, and detailed charts
GelStat Corp. (GSAC/GSAC.PK) Wrap Up:
GelStat Corporation engages in the development and marketing of over the counter and other nonprescription consumer health care products for pain and inflammation. It markets GelStat Migraine, a homeopathic drug, for the treatment of migraine and migraine-like headaches, as well as GelStat Arthritis, a sublingual dissolving tablet for the treatment of pain and associated symptoms of arthritis. The company is also developing other products that are in the final stages of development, which include GelStat Sinus for the remedy of nasal and/or sinus congestion, irritation, pressure, and sinus headache; and GelStat Sleep for promoting restful sleep. The company sells its products to regional and...GelStat Corp. (GSAC:OTC)
|
Market Cap
467.3K
|
Total Revenue
26.2K
|
|
|
EBITDA
1.2M
|
DILUTED EPS TTM
-0.05
|
|
|
P/E
--
|
P/S
17.2x
|
|
|
Return On Asset
--
|
Return On Equity
--
|
|
| K = Thousands M = Millions B = Billions | ||
GSAC Top Compensated Officers
Executives, Board Directors
Key developments for GelStat Corp. (GSAC)
GelStat Corporation has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common stock under the Securities Exchange Act of 1934, as amended.
GelStat Corp. announced that Gerald N. Kieft has accepted the position as Chief Executive Officer and that Adrian Goldfarb has been appointed to the Company's Board of Directors. Bill Colucci resigned from his position as the Company's President on June 20, 2008 in order to begin the process of entering into semi-retirement and is divesting himself of various responsibilities. Mr. Colucci will remain serving on the Company's Board of Directors. Mr. Kieft and Mr. Goldfarb are co-founders of WSR Consulting Inc. which was retained in March of 2008 to lead the turn around of the Company. At this time, neither Mr. Kieft nor Mr. Goldfarb have requested any additional compensation for their expanded duties at GelStat.
GelStat Corp. announced that Mr. Michael Chavanu has been appointed as the Company's new Chairman of the Board replacing Mr. James LaFlamme who resigned to pursue other opportunities which prohibit him from serving on any public company boards. Mr. Chavanu has served on the Company's board since June of 2006.
GSAC Competitors
| Company | Last | Change | |
| No competitor information is available for GSAC. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | GSAC | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 17.2x |
|
| Price/Book | 0.3x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
GSAC |
||
GSAC transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||